Nathan Geffen

516 total citations
28 papers, 287 citations indexed

About

Nathan Geffen is a scholar working on Infectious Diseases, Economics and Econometrics and Virology. According to data from OpenAlex, Nathan Geffen has authored 28 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 11 papers in Economics and Econometrics and 6 papers in Virology. Recurrent topics in Nathan Geffen's work include HIV/AIDS Research and Interventions (16 papers), HIV/AIDS Impact and Responses (10 papers) and HIV/AIDS drug development and treatment (8 papers). Nathan Geffen is often cited by papers focused on HIV/AIDS Research and Interventions (16 papers), HIV/AIDS Impact and Responses (10 papers) and HIV/AIDS drug development and treatment (8 papers). Nathan Geffen collaborates with scholars based in South Africa, United Kingdom and United States. Nathan Geffen's co-authors include Edwin Cameron, Leigh F. Johnson, Nicoli Nattrass, Simon Collins, Marcus Low, Alex Welte, François Venter, Polly Clayden, Siegfried Schwarze and Michael Meulbroek and has published in prestigious journals such as The Lancet, JAIDS Journal of Acquired Immune Deficiency Syndromes and Sexually Transmitted Diseases.

In The Last Decade

Nathan Geffen

28 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Geffen South Africa 9 133 110 87 66 63 28 287
Marco Rizzi Australia 9 101 0.8× 45 0.4× 52 0.6× 72 1.1× 27 0.4× 49 350
L Reynolds South Africa 8 112 0.8× 118 1.1× 58 0.7× 56 0.8× 24 0.4× 22 245
Bridget Stirling Canada 10 140 1.1× 153 1.4× 92 1.1× 92 1.4× 31 0.5× 17 376
Esca Scheepers South Africa 9 134 1.0× 273 2.5× 116 1.3× 31 0.5× 37 0.6× 18 440
William W. Rankin United States 5 145 1.1× 142 1.3× 73 0.8× 69 1.0× 34 0.5× 15 274
Caterina Hill United Kingdom 7 131 1.0× 102 0.9× 65 0.7× 88 1.3× 61 1.0× 9 312
Pinky Kunene South Africa 8 192 1.4× 183 1.7× 59 0.7× 99 1.5× 28 0.4× 10 280
Todd Koppenhaver United States 9 124 0.9× 144 1.3× 105 1.2× 63 1.0× 35 0.6× 10 302
Titilola Gbaja‐Biamila Nigeria 11 164 1.2× 132 1.2× 28 0.3× 88 1.3× 43 0.7× 50 342
Wairagala Wakabi Sweden 10 47 0.4× 117 1.1× 61 0.7× 29 0.4× 35 0.6× 58 388

Countries citing papers authored by Nathan Geffen

Since Specialization
Citations

This map shows the geographic impact of Nathan Geffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Geffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Geffen more than expected).

Fields of papers citing papers by Nathan Geffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Geffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Geffen. The network helps show where Nathan Geffen may publish in the future.

Co-authorship network of co-authors of Nathan Geffen

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Geffen. A scholar is included among the top collaborators of Nathan Geffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Geffen. Nathan Geffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chersich, Matthew, Nkuli Mashabane, Marlise Richter, et al.. (2018). Quality of counselling and support provided by the South African National AIDS Helpline: Content analysis of mystery client interviews. South African Medical Journal. 108(7). 596–596. 3 indexed citations
2.
Geffen, Nathan & Alex Welte. (2018). Modelling the human immunodeficiency virus (HIV) epidemic: A review of the substance and role of models in South Africa. Southern African Journal of HIV Medicine. 19(1). 756–756. 4 indexed citations
3.
Geffen, Nathan & Marcus Low. (2017). When to start antiretroviral treatment? A history and analysis of a scientific controversy. Southern African Journal of HIV Medicine. 18(1). 734–734. 7 indexed citations
4.
Geffen, Nathan. (2017). The role of activists in access to HIV and tuberculosis treatment and prevention. Current Opinion in HIV and AIDS. 12(4). 398–402. 5 indexed citations
5.
Geffen, Nathan & Stefan Scholz. (2017). Efficient and Effective Pair-Matching Algorithms for Agent-Based Models. Journal of Artificial Societies and Social Simulation. 20(4). 1 indexed citations
6.
Johnson, Leigh F. & Nathan Geffen. (2016). A Comparison of Two Mathematical Modeling Frameworks for Evaluating Sexually Transmitted Infection Epidemiology. Sexually Transmitted Diseases. 43(3). 139–146. 34 indexed citations
7.
Geffen, Nathan, et al.. (2015). Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine. 16(S1). 10–13. 12 indexed citations
8.
Geffen, Nathan, et al.. (2014). One size doesn’t fit all: Tailoring adult antiretroviral treatment. Southern African Journal of HIV Medicine. 15(3). 77–78. 2 indexed citations
9.
Geffen, Nathan, et al.. (2014). One size doesn’t fit all: Tailoring adult antiretroviral treatment. Southern African Journal of HIV Medicine. 15(3). 77–77. 3 indexed citations
10.
Collins, Simon & Nathan Geffen. (2013). Community views. Current Opinion in HIV and AIDS. 9(1). 4–10. 9 indexed citations
11.
Geffen, Nathan. (2013). World Health Organization guidelines should not change the CD4 count threshold for antiretroviral therapy initiation. Southern African Journal of HIV Medicine. 14(1). 5 indexed citations
12.
Geffen, Nathan. (2013). World Health Organization guidelines should not change the CD4 count threshold for antiretroviral therapy initiation. Southern African Journal of HIV Medicine. 14(1). 6–7. 2 indexed citations
13.
Geffen, Nathan. (2011). When to start ART in adults? The results of HPTN 052 move us closer to a test-and-treat policy. Southern African Journal of HIV Medicine. 12(3). 9–9. 3 indexed citations
14.
Geffen, Nathan. (2009). Justice After AIDS Denialism: Should There Be Prosecutions and Compensation?. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(4). 454–455. 8 indexed citations
15.
Geffen, Nathan & Edwin Cameron. (2009). The deadly hand of denial: Governance and politically-instigated AIDS denialism in South Africa. Open University of Cape Town (University of Cape Town). 3 indexed citations
16.
Geffen, Nathan. (2009). Beyond HAART: scientists and activists need to work together. The Lancet. 374(9693). 860–861. 7 indexed citations
17.
Auvert, Bertran, Pascale Lissouba, Dirk Taljaard, et al.. (2009). Key facts on male circumcision.. PubMed. 99(3). 150–1. 4 indexed citations
18.
Geffen, Nathan. (2007). ENCOURAGING DEADLY CHOICES: AIDS PSEUDO-SCIENCE IN THE MEDIA. Open University of Cape Town (University of Cape Town). 3 indexed citations
19.
Cameron, Edwin & Nathan Geffen. (2005). Witness To Aids. Medical Entomology and Zoology. 63 indexed citations
20.
Nattrass, Nicoli & Nathan Geffen. (2005). The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa. African Journal of AIDS Research. 4(1). 65–67. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026